Jochen Kumm

Jochen Kumm has a diverse work experience in the healthcare and AI industries. Jochen is currently the CEO of Pr3vent INC since September 2018. Previously, they were the founder of PLACID0, Inc., where they served as a founder and later as a co-founder focused on developing algorithms for mapping the eye. Jochen also founded Redmynd AI and served as a founder and inventor. Additionally, Jochen was the StartX Med Founder at StartX from October 2019 to August 2020.

In the AI and genomics sector, Jochen founded insightAI, an AI company for genomics and health, and served as the founder from October 2016 to December 2018. Jochen was also the Genomics & Bioinformatics Lead at NGX Bio from August 2015 to August 2016. Jochen's experience at IBM Research involved working on projects in Live Sciences and Healthcare, as well as serving as the Head of Healthcare for IBM Research Africa.

Earlier in their career, Jochen was the VP of Bioinformatics at Veracyte, Inc. in 2013. Jochen also had a role as a Visiting Scholar at Stanford University School of Medicine from February 2016 to January 2018.

Furthermore, Jochen had a role as the CTO at Greenteaspoon, where they worked on providing prebiotics to improve health and reduce inflammation from January 2017 to January 2018.

Overall, Jochen Kumm has extensive experience as a founder, CEO, and leader in the AI, genomics, and healthcare sectors.

Jochen Kumm has a strong educational background in the field of biological sciences. Jochen obtained a PhD degree from Stanford University, where they studied from 1989 to 1994. Prior to that, they completed their Bachelor of Arts degree in Biology at Harvard University, which they attended from 1987 to 1989. Jochen also has a Physicum degree in Medicine from Heidelberg University, where they studied in 1985 and 1986. Before pursuing higher education, Jochen Kumm completed their International Baccalaureate at Lester B. Pearson College from 1983 to 1985, focusing on a general field of study.